Biotech

First China Pharma Announces Audited Financials and Issues Guidance

KUNMING, CHINA: ...

Lorus Therapeutics and Genentech Sign Global Intellectual Property License Agreement for IL-17E in Cancer

TORONTO, ONTARIO: ...

Prana Comments on Archives of Neurology Publication Which Highlights Critical Role of Brain Metals in Huntington Disease Progression

MELBOURNE, AUSTRALIA: MGH Team Publishes Data That Supports the Use of PBT2 in Huntington Disease ...

Functional Technologies Reports Growing Industry Interest for its Acrylamide-Preventing Yeasts

VANCOUVER, BRITISH COLUMBIA: ...

Functional Technologies Reports Second Quarter 2012 Financial Results

VANCOUVER, BRITISH COLUMBIA: ...

The Medicines Company to Participate in the Deutsche Bank 37th Annual Healthcare Conference

PARSIPPANY, NJ: ...

Prana Enrolls First Patient in the "Reach2HD" Phase II Huntington Disease Trial

MELBOURNE, AUSTRALIA: Huntington Study Group Initiates First Site at University of California, San Diego School of Medicine ...

Start Spreading the News... New York, New York Welcomes Pharma Back for INTERPHEX 2012, an Industrial Info News Alert

SUGAR LAND, TX: ...

RepliCel Clarifying News Release

VANCOUVER, BRITISH COLUMBIA: ...

Critical Outcome Technologies Inc. Completes Financing

LONDON, ONTARIO: ...